PAA is the only Oncology company to have carried out a Phase II Human Trial and have a MC under $100m.
Regulatory Permission was given back in 2016 to reformulate and carry out a Phase IIb Human Trial .... reformulation has been on the agenda for 5 years now.
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=366350 PAA Human Cancer Trial Link.
. Sufficient data was obtained to permit proceeding to Phase II study, i.e. a safe and active dose. The study was also terminated to permit reformulation of study drug to a more palatable formulation
Quarterly will be out in 10 days... I hope PAA aren't saving news for that....
Maybe an idea to have the CEO in the same Hemisphere as the company??
PAA is the only Oncology company to have carried out a Phase II...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.015(7.69%) |
Mkt cap ! $93.45M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.5¢ | 19.5¢ | $413.7K | 2.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 122718 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 90521 | 3 |
View Market Depth
| Last trade - 15.51pm 11/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |